Velpatasvir

ATC — · 10 markets · 36 records

Velpatasvir 10 markets · 36 records Forms

GB 7 records · 4 strengths

US 6 records · 4 strengths

AU 6 records · 2 strengths

  • 100 mgtabletEpclusaEPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle、Vosevi、VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle also in GB·US·ES +2 unknown

Records without a stated strength · 1 Epclusa、Vosevi

ES 6 records · 4 strengths

Records without a stated strength · 1 Vosevi

CA 2 records · 1 strengths

SG 2 records · 1 strengths

TW 2 records · 1 strengths

    Records without a stated strength · 1 Epclusa、Vosevi、宜譜莎 膜衣錠、沃士維膜衣錠 +1

    HK 2 records · 1 strengths

      Records without a stated strength · 1 Epclusa、Vosevi

      EU 2 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Epclusa、Vosevi

        MX 1 records · 1 strengths

          Records without a stated strength · 1 Vosevi

          Side-by-side table

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.